Researchers are determining that simply not having enough participants to fill a clinical trial is not enough-diversity is an essential element in research trials. Electra Paskett, co-director of the Diversity Enhancement Program at the Arthur G. James Cancer Hospital...
A study published in the Journal of the American Medical Informatics Association analyzed whether people were more inclined to develop blood clots in the arms and legs depending on their height and weight. The team of researchers at MetroHealth Medical Center and...
BioCrossroads is once again presenting the Indiana Life Sciences Summit conference to be held at the Westin Indianapolis on October 22-23, 2012. The event features executive speakers from companies such as Eli Lilly and Company and Roche Diagnostics. Pearl will be...
Check out the 2012 IBJ Biofutures article covering our expansion last year to Pearl Pathways using this link. You will need to page through to the article on page 33. Key quotes include: “Our clients shaped the direction of our future growth,” says Diana Caldwell,...
During an April 23rd FDA hearing to gather input on ways to modernize the clinical research process, The Association of Clinical Research Organizations (ACRO) provided FDA a number of suggestions to improve the drug development process. ACRO’s main suggestion was to...